메뉴 건너뛰기
Clinical Nephrology
Volumn 74, Issue 4, 2010, Pages 308-310
Rituximab for steroid-dependent nephrotic syndrome
Author keywords

Minimal change disease; Nephrotic syndrome; Rituximab
Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; LEVAMISOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; STEROID;
EID: 77957684029     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (12)
References (7)
  • 1
    • 56749093213 scopus 로고    scopus 로고
    • Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: Report of four cases and review of the literature
    • Peters HP, van de Kar NC, Wetzels JF. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature. Neth J Med. 2008; 66: 408-415.
    • (2008) Neth J Med , vol.66 , pp. 408-415
    • Peters, H.P.1    Van De Kar, N.C.2    Wetzels, J.F.3
  • 2
    • 33845586060 scopus 로고    scopus 로고
    • Unexpected Efficacy of Rituximab in Multirelapsing Minimal Change Nephrotic Syndrome in the Adult: First Case Report and Pathophysiological Considerations
    • DOI 10.1053/j.ajkd.2006.10.015, PII S0272638606016143
    • Francois H, Daugas E, Bensman A, Ronco P. Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations. Am J Kidney Dis. 2007; 49: 158-161. (Pubitemid 44932200)
    • (2007) American Journal of Kidney Diseases , vol.49 , Issue.1 , pp. 158-161
    • Francois, H.1    Daugas, E.2    Bensman, A.3    Ronco, P.4
  • 3
    • 44449149293 scopus 로고    scopus 로고
    • Rapid remission of steroid and mycophenolate mofetil (mmf) - Resistant minimal change nephrotic syndrome after rituximab therapy
    • DOI 10.1093/ndt/gfm592
    • Yang T, Nast CC, Vo A, Jordan SC. Rapid remission of steroid and mycophenolate mofetil (MMF)-resistant minimal change nephrotic syndrome after rituximab therapy. Nephrol Dial Transplant. 2008; 23: 377-380. (Pubitemid 351767391)
    • (2008) Nephrology Dialysis Transplantation , vol.23 , Issue.1 , pp. 377-380
    • Yang, T.1    Nast, C.C.2    Vo, A.3    Jordan, S.C.4
  • 4
    • 34547843560 scopus 로고    scopus 로고
    • Rituximab: Effective treatment for severe steroid-dependent minimal change nephrotic syndrome?
    • Hofstra JM, Deegens JK, Wetzels JF. Rituximab: effective treatment for severe steroid-dependent minimal change nephrotic syndrome? Nephrol Dial Transplant. 2007; 22: 2100-2102.
    • (2007) Nephrol Dial Transplant , vol.22 , pp. 2100-2102
    • Hofstra, J.M.1    Deegens, J.K.2    Wetzels, J.F.3
  • 5
    • 77957685487 scopus 로고    scopus 로고
    • Rituximab treatment for severe steroid- or cyclosporinedependent nephrotic syndrome: A multicentric series of 22 cases
    • Guigonis V, Dallocchio A, Baudouin V et al. Rituximab treatment for severe steroid- or cyclosporinedependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol. 2009; 24: 423-424.
    • (2009) Pediatr Nephrol , vol.24 , pp. 423-424
    • Guigonis, V.1    Dallocchio, A.2    Baudouin, V.3
  • 6
    • 0026002605 scopus 로고
    • A glomerular permeability factor produced by human T cell hybridomas
    • Koyama A, Fujsaki M, Kobayashi M et al. A glomerular permeability factor produced by human T cell hybridomas. Kidney Int. 1991; 40: 453-460.
    • (1991) Kidney Int , vol.40 , pp. 453-460
    • Koyama, A.1    Fujsaki, M.2    Kobayashi, M.3
  • 7
    • 44449172514 scopus 로고    scopus 로고
    • Rituximab and nephrotic syndrome: A new therapeutic hope?
    • Ahmed MS, Wong CF. Rituximab and nephrotic syndrome: a new therapeutic hope? Nephrol Dial Transplant. 2008; 23: 11-17.
    • (2008) Nephrol Dial Transplant. , vol.23 , pp. 11-17
    • Ahmed, M.S.1    Wong, C.F.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.